[Small bowel transplantation].
Fukuzawa
Masahiro
M
Department of Pediatric Surgery, Osaka University Graduate School of Medicine.
D000818:Animals; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D006084:Graft Rejection / Q000517:prevention & control*; D006085:Graft Survival; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D007410:Intestinal Diseases / Q000628:therapy*; D007421:Intestine, Small / Q000637:transplantation*; D011379:Prognosis; D015375:Receptors, Interleukin-2 / Q000276:immunology; D016559:Tacrolimus; D019172:Transplantation Conditioning
D000911:Antibodies, Monoclonal; D007166:Immunosuppressive Agents; D015375:Receptors, Interleukin-2; D016559:Tacrolimus